Siemens Healthineers AG (OTCMKTS:SMMNY) Given Average Rating of “Buy” by Analysts

Shares of Siemens Healthineers AG (OTCMKTS:SMMNY) have been assigned an average recommendation of “Buy” from the seven ratings firms that are covering the stock, Marketbeat reports. Two analysts have rated the stock with a hold rating, two have given a buy rating and three have issued a strong buy rating on the company.

SMMNY has been the subject of several recent analyst reports. Deutsche Bank Aktiengesellschaft cut shares of Siemens Healthineers from a “buy” rating to a “hold” rating in a research report on Thursday, December 4th. Royal Bank Of Canada initiated coverage on Siemens Healthineers in a report on Wednesday, December 17th. They set a “moderate buy” rating for the company. Citigroup reissued a “buy” rating on shares of Siemens Healthineers in a research note on Friday, January 23rd. Sanford C. Bernstein raised Siemens Healthineers to a “strong-buy” rating in a research note on Tuesday, January 13th. Finally, Zacks Research upgraded Siemens Healthineers from a “strong sell” rating to a “hold” rating in a report on Monday, January 12th.

Siemens Healthineers Stock Performance

Siemens Healthineers stock opened at $24.85 on Friday. Siemens Healthineers has a 52-week low of $23.28 and a 52-week high of $29.00. The firm has a 50 day moving average price of $25.60 and a two-hundred day moving average price of $26.36.

Siemens Healthineers Company Profile

Siemens Healthineers AG is a leading global medical technology company that develops, manufactures and distributes a broad range of products and services for the healthcare sector. Headquartered in Erlangen, Germany, the company focuses on diagnostic and therapeutic imaging, in vitro diagnostics and advanced digital health solutions. As a spin-off from Siemens AG, Siemens Healthineers has leveraged decades of engineering expertise to establish a comprehensive portfolio that addresses critical needs in modern healthcare.

The company’s core offerings include magnetic resonance imaging (MRI), computed tomography (CT), X-ray and molecular imaging systems, as well as laboratory diagnostics equipment and point-of-care testing devices.